Adès, L., Lane, S., Garnier, A., Cluzeau, T., Rauzy, O., Götze, K. S., Giagounidis, A., Singhal, D., Brauer, D., Grove, C., Mohr, K., Chermat, F., Nkyekyer, J., Platzbecker, U. (2025). A phase II study evaluating the efficacy and safety of imetelstat in patients with advanced myelodysplastic neoplasms or AML failing HMA-based therapy – interim analysis results of the IMpress study. Blood. https://doi.org/10.1182/blood-2025-5155